(Q51143982)

31 March 2018

title

Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids. (English)

1 reference

31 March 2018

chronic obstructive pulmonary disease

main subject

1 reference

Diahn-Warng Perng

1

1 reference

31 March 2018

Cheng-Che Wu

2

1 reference

31 March 2018

Kang-Cheng Su

3

1 reference

31 March 2018

Yu-Chin Lee

4

1 reference

31 March 2018

Reury-Perng Perng

5

1 reference

31 March 2018

Chi-Wei Tao

6

1 reference

31 March 2018

publication date

1 September 2006

1 reference

31 March 2018

published in

Respirology

1 reference

31 March 2018

volume

11

1 reference

31 March 2018

issue

5

1 reference

31 March 2018

page(s)

598-602

1 reference

31 March 2018

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

The functional impact of adding salmeterol and tiotropium in patients with stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2006.00889.X

10.1111/J.1440-1843.2006.00889.X

21 January 2018

Identifiers

DOI

1 reference

31 March 2018

PubMed ID

16916333

1 reference

31 March 2018